Upcoming events

DES: updated evidence from randomised clinical trials

Presentations available when logged in:

  • BIOTRONIK: safety and clinical performance of the DES orsiro in the treatment of subjects with single de novo coronary artery lesions II (BIOFLOW-I...
  • Comparison of biodegradable polymer and durable polymer drug-eluting stents in an all comers patient population (BIO-RESORT) : rationale and study...
  • Improved safety and reduction in stent thrombosis associated with biodegradable polymer based biolimus-eluting stents versus durable polymer based...
  • Direct implantation of rapamycin-eluting stents with bioerodible drug carrier technology utilising a next generation DES coronary integrated delive...
  • BIOFLOW-III an "All Comers" registry with a sirolimus-eluting stent, presentation of one year target lesion failure rata